Side branch embolization before endovascular abdominal aortic aneurysm repair to prevent type II endoleak: A prospective multicenter study.
Tomoyuki Gentsu, Masato Yamaguchi, Koji Sasaki...
https://pubmed.ncbi.nlm.nih.gov/38503637/Actively Recruiting
Led by Groupe Hospitalier de la Rochelle Ré Aunis · Updated on 2025-06-18
300
Participants Needed
1
Research Sites
43 weeks
Total Duration
This research aims to assess the use of artificial intelligence to predict complications following abdominal aortic endoprosthesis treatment for abdominal aortic aneurysms AAA. Abdominal aortic aneurysm involves enlargement of the aortas diameter and can be treated surgically or with an endovascular prosthesis. Although endovascular treatment is less invasive, its long-term effects are not fully known, and patients require ongoing monitoring for complications such as endoleaks, where blood leaks around the prosthesis. The study focuses on patients treated with an abdominal aortic endoprosthesis, a device made of a metal spring covered with impermeable fabric, inserted via an artery into the aorta. Treatment indications include AAAs larger than 50 mm in women or 55 mm in men, or those showing rapid size increase, as well as symptomatic or complicated AAAs. Researchers will evaluate whether a machine learning algorithm analyzing initial CT scan images can predict the risk of endoleaks and other complications. Participants will be monitored for two years after prosthesis placement, with researchers tracking the number of endoleaks, embolizations, sac size changes, and serious adverse events. Data collection will include imaging analysis and clinical follow-up to understand complication rates and prosthesis performance. This long-term observation aims to better predict and manage risks associated with endovascular AAA treatment.
CONDITIONS
Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery
C
Caroline Allix-Béguec, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Groupe Hospitalier de la Rochelle Ré Aunis
Lead Sponsor
La Rochelle University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo placement of an abdominal aortic endoprosthesis through an artery to treat their abdominal aortic aneurysm.
1 visit (in-person)
Duration - Up to 2 years
Participants are monitored for complications such as endoleaks and sac size changes following endoprosthesis placement, with follow-up assessments focused on managing potential complications and vascular health.
Regular follow-up visits over 2 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Tomoyuki Gentsu, Masato Yamaguchi, Koji Sasaki...
https://pubmed.ncbi.nlm.nih.gov/38503637/Giovanni Tinelli, Mario D'Oria, Simona Sica...
https://pubmed.ncbi.nlm.nih.gov/38462062/Makoto Samura, Noriyasu Morikage, Ryo Otsuka...
https://pubmed.ncbi.nlm.nih.gov/30946077/Groupe Hospitalier de la Rochelle Ré Aunis
Lead Sponsor
La Rochelle University
Collaborating Sponsor